Stanczyk, 2016 - Google Patents
Characterisation of a novel interaction between the cardiac myosin binding protein-C and the ryanodine receptor/calcium release channelStanczyk, 2016
View PDF- Document ID
- 795372970203761261
- Author
- Stanczyk P
- Publication year
External Links
Snippet
Muscle excitation-contraction coupling (ECC) is a fundamental physiological process by which electrically-evoked sarcoplasmic reticulum (SR) Ca2+ release triggers cardiomyocyte contraction. Human ryanodine receptor 2 (RyR2) is an ion channel present in the SR …
- 230000027455 binding 0 title abstract description 105
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| van der Ven et al. | Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP | |
| WO1998009980A9 (en) | Bh3 interacting domain death agonist | |
| AU4411197A (en) | Bh3 interacting domain death agonist | |
| KR20210117271A (en) | Use of annexin to prevent and treat myofascial injuryUse of annexin to prevent and treat muscle damage | |
| US20080161259A1 (en) | Inhibitory pellion nucleic acids | |
| WO2018057648A1 (en) | Peptide regulators of mitochondrial fusion and methods of use | |
| WO2002026780A2 (en) | Paad domain-containing polypeptides, encoding nucleic acids, and methods of use | |
| US20030077699A1 (en) | PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use | |
| CN116981480A (en) | Anti-synucleinopathy peptides and methods for treating neurodegenerative diseases | |
| US20110189711A1 (en) | Paad domain-containing polypeptides, encoding nucleic acids, and methods of use | |
| Stanczyk | Characterisation of a novel interaction between the cardiac myosin binding protein-C and the ryanodine receptor/calcium release channel | |
| US20110086089A1 (en) | Use of p27kip1 for the prevention and treatment of heart failure | |
| AU756370B2 (en) | Myotilin, an actin-organizing protein | |
| Zallocchi et al. | Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells | |
| JP2021507680A (en) | Calcium chelated peptide derived from EF hand calcium binding motif | |
| US20100317598A1 (en) | Isolated BRCA1 Peptides and Method of Use | |
| Axelrod | Investigations into Mitochondrial Cell Death Mechanisms in Myocardial Infarction | |
| Young | Turning Autophagy On and Off through the Class III PI-3 Kinase | |
| Cooley | Dysregulated Membrane Trafficking and the Development of Pancreatitis | |
| Nougarede | Molecular basis of BCL2L10/Nrh oncogenic activity in breast cancer | |
| Gorski | Molecular insights into SERCA regulation by endogenous peptide modulators | |
| Thomas | Molecular mechanisms underlying cardiac ryanodine receptor dysfunction in sudden cardiac death. | |
| Wang | Multifaceted Regulation of Neuronal L-Type Ca2+ Channels by the N-Terminal Domain: from CaMKII Targeting to Nuclear Signaling | |
| Desmond | Identification of Small Ankyrin 1 as a novel SERCA1 regulatory protein in Skeletal Muscle | |
| Evans | Spastin, a microtubule severing enzyme, interacts with Atlastin: Two HSP genes suggesting a common pathway for axonal maintenance |